Free Trial

Genus (GNS) Competitors

Genus logo
GBX 2,611.27 +71.27 (+2.81%)
As of 11:58 AM Eastern

GNS vs. HWDN, DPH, IGG, CTY, SMWH, KYGA, CAR, PRP, AUK, and STG

Should you be buying Genus stock or one of its competitors? The main competitors of Genus include Howden Joinery Group (HWDN), Dechra Pharmaceuticals (DPH), IG Group (IGG), City of London (CTY), WH Smith (SMWH), Kerry Group (KYGA), Carclo (CAR), Prime People (PRP), Aukett Swanke Group (AUK), and Strip Tinning (STG). These companies are all part of the "personal services" industry.

Genus vs. Its Competitors

Genus (LON:GNS) and Howden Joinery Group (LON:HWDN) are both personal services companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, media sentiment, earnings and dividends.

63.4% of Genus shares are held by institutional investors. Comparatively, 67.4% of Howden Joinery Group shares are held by institutional investors. 0.7% of Genus shares are held by insiders. Comparatively, 0.9% of Howden Joinery Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Howden Joinery Group had 2 more articles in the media than Genus. MarketBeat recorded 4 mentions for Howden Joinery Group and 2 mentions for Genus. Genus' average media sentiment score of 1.11 beat Howden Joinery Group's score of 0.43 indicating that Genus is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Genus
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Howden Joinery Group
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Genus pays an annual dividend of GBX 0.32 per share and has a dividend yield of 0.0%. Howden Joinery Group pays an annual dividend of GBX 0.21 per share and has a dividend yield of 0.0%. Genus pays out 110.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Howden Joinery Group pays out 45.8% of its earnings in the form of a dividend. Howden Joinery Group is clearly the better dividend stock, given its higher yield and lower payout ratio.

Howden Joinery Group has higher revenue and earnings than Genus. Howden Joinery Group is trading at a lower price-to-earnings ratio than Genus, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Genus£672.80M2.57£7.87M£0.299,035.53
Howden Joinery Group£2.35B1.89£253.42M£0.461,775.90

Genus has a beta of 0.37, suggesting that its share price is 63% less volatile than the S&P 500. Comparatively, Howden Joinery Group has a beta of 1.07, suggesting that its share price is 7% more volatile than the S&P 500.

Genus currently has a consensus price target of GBX 2,900, suggesting a potential upside of 11.06%. Howden Joinery Group has a consensus price target of GBX 919.67, suggesting a potential upside of 11.85%. Given Howden Joinery Group's higher possible upside, analysts clearly believe Howden Joinery Group is more favorable than Genus.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Genus
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Howden Joinery Group
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

Howden Joinery Group has a net margin of 10.82% compared to Genus' net margin of 1.18%. Howden Joinery Group's return on equity of 25.70% beat Genus' return on equity.

Company Net Margins Return on Equity Return on Assets
Genus1.18% 1.41% 3.31%
Howden Joinery Group 10.82%25.70%10.70%

Summary

Howden Joinery Group beats Genus on 13 of the 18 factors compared between the two stocks.

Get Genus News Delivered to You Automatically

Sign up to receive the latest news and ratings for GNS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GNS vs. The Competition

MetricGenusBiotechnology IndustryMedical SectorLON Exchange
Market Cap£1.73B£231.79M£6.14B£2.61B
Dividend Yield1.26%3.80%5.66%5.28%
P/E Ratio9,035.5396.9485.844,440.52
Price / Sales2.576,073.88621.60100,568.44
Price / Cash50.5613.1938.3227.90
Price / Book3.15113.4713.068.88
Net Income£7.87M-£90.99M£3.30B£5.89B
7 Day Performance3.62%3.98%4.81%0.81%
1 Month Performance-3.11%6.29%9.99%5.86%
1 Year Performance21.26%725.82%85.28%154.98%

Genus Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GNS
Genus
1.7243 of 5 stars
GBX 2,611.27
+2.8%
GBX 2,900
+11.1%
+23.3%£1.73B£672.80M9,035.53480Gap Down
HWDN
Howden Joinery Group
1.9072 of 5 stars
GBX 838.50
+0.2%
GBX 919.67
+9.7%
-6.7%£4.55B£2.35B1,811.0212,000
DPH
Dechra Pharmaceuticals
N/AN/AN/AN/A£4.40B£761.50M-15,464.002,457
IGG
IG Group
3.9069 of 5 stars
GBX 1,065
+0.4%
GBX 1,470.67
+38.1%
+18.4%£3.71B£949.10M1,013.322,754Insider Trade
CTY
City of London
N/AGBX 502
-0.6%
N/A+18.8%£2.49B£222.11M1,135.75N/ADividend Announcement
SMWH
WH Smith
2.5018 of 5 stars
GBX 673.85
-0.6%
GBX 998.20
+48.1%
-53.5%£839.35M£1.94B14,974.4414,935Dividend Increase
KYGA
Kerry Group
N/AGBX 76
-2.1%
N/A-16.5%£123.76M£6.97B17.3021,000Gap Down
CAR
Carclo
N/AGBX 57.62
-1.3%
N/A+103.7%£42.30M£121.22M4,801.501,059
PRP
Prime People
N/AN/AN/AN/A£8.15M£19.72M10.9813,100Gap Down
AUK
Aukett Swanke Group
N/AN/AN/AN/A£5.46M£23.61M-6.3232,200Gap Down
STG
Strip Tinning
N/AGBX 24
+4.3%
N/A-37.1%£4.37M£8.78M-123.904,060Gap Down
High Trading Volume

Related Companies and Tools


This page (LON:GNS) was last updated on 10/9/2025 by MarketBeat.com Staff
From Our Partners